ClinicalTrials.Veeva

Menu
D

DelRicht Research | Neighborhood Health - Prairieville, LA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Viloxazine
NRCT-101SR
X0002
SPN-812
PF-08653944
PF-08653945
STS101
Galcanezumab
EVO100
Tolperisone

Parent organization

This site is a part of DelRicht Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 12 total trials

A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1)

This study is being done to learn about the safety and effects of the study drugs, PF-08653945 and PF-08653944, when given alone or together for weig...

Enrolling
Overweight and/or Obesity
Nutrition Disorders
Drug: PF-08653944
Drug: PF-08653945

The purpose of this study is to evaluate the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age wi...

Active, not recruiting
SARS-CoV-2
Biological: mRNA-1283
Biological: mRNA-1273

The purpose of this study is to evaluate how well CD388 works in preventing symptomatic laboratory-confirmed influenza infections, as compared to pla...

Active, not recruiting
Influenza
Combination Product: CD388 Injection
Combination Product: Placebo

This study will evaluate the efficacy and safety of SPN-812 (viloxazine extended release) in children 4 to 5 years of age with ADHD.

Enrolling
Attention-Deficit/Hyperactivity Disorder
Drug: Placebo
Drug: 100mg SPN-812

Trial sponsors

Moderna logo
C
E
Lilly logo
N
N
Pfizer logo
S
Supernus Pharmaceuticals logo
Techfields logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems